Author

Holly E. Barker

The University of MelbourneORCID 0000-0002-9350-5520Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Approach:statistical model· 2 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Organism:mouse· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Cassandra J. VandenbergiD· 2 shared A. Ferrier· 1 shared A. Glasgow· 1 shared A. Mellon· 1 shared Adam C. Martyn· 1 shared Adèle C. GreeniD· 1 shared Alexander DobroviciD· 1 shared Amelia Dunstone· 1 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

Cassandra J. VandenbergORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Genetic & Genomic MedicineMolecular CancerPeer-reviewedAug 5, 2024

BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance

Ksenija Nesic, John J. Krais, Yifan Wang…·Lyndal S. Edwards

This study identifies secondary splice-site mutations in BRCA1 that drive exon skipping and PARP inhibitor resistance in ovarian and breast cancer.

36 citationstop 2%

humanbulk RNA-seq

𝕏 PostBluesky

GenomicsGenomicsPeer-reviewedJan 19, 2024

A Risk-reward Examination of Sample Multiplexing Reagents for Single Cell RNA-Seq

Daniel V. Brown, Casey J. A. Anttila, Ling Ling…·Rory J. Bowden

This study evaluates sample multiplexing reagents and protocols for scRNA-Seq, finding that workflow improvements and reagent choice impact data quality and cost-effectiveness.

26 citations

𝕏 PostBluesky